Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
RATIONALE: Studying samples of blood and tumor tissue from patients with cancer may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. Storing samples to test in the laboratory may help the study of cancer in the future.
PURPOSE: This research study is collecting and storing blood and tumor tissue samples from patients undergoing prostatectomy or transurethral resection of the prostate.
| Condition |
|---|
|
Prostate Cancer |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Assessment of Tumor Resistance and Stem Cells in Prostate Cancer |
- Collection and freezing of tumor samples [ Time Frame: 5 years ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples With DNA
Samples will be collected at time of TURP and will be deidentified and processed by standard procedures.
| Estimated Enrollment: | 100 |
| Study Start Date: | December 2008 |
| Study Completion Date: | December 2008 |
| Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
OBJECTIVES:
- Collect prostate tissue and other biological specimens for assessment of biological markers that may relate to tumor progression and resistance and for future isolation of stem cells and biologic markers.
Biological samples, including serum and mononuclear cells and tumor tissue, are collected before and during surgery. Specimens are frozen and stored indefinitely.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Any patient undergoing a routine prostatectomy or TURP (transurethral resection of the prostate) may be asked to participate
DISEASE CHARACTERISTICS:
- Undergoing routine prostatectomy or transurethral resection of the prostate (TURP)
PATIENT CHARACTERISTICS:
5.1.1 Patient is undergoing routine prostatectomy or TURP.
5.1.2 Patient is ≥ 18 years old.
5.1.3 Patient must give informed consent.
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Contacts and Locations| United States, New Jersey | |
| Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School | |
| New Brunswick, New Jersey, United States, 08903 | |
| Principal Investigator: | Isaac Kim, MD, PhD | Cancer Institute of New Jersey |
More Information
Additional Information:
No publications provided
| Responsible Party: | Isaac Kim, Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School |
| ClinicalTrials.gov Identifier: | NCT00991315 History of Changes |
| Other Study ID Numbers: | CDR0000648129, P30CA072720, CINJ-080809 |
| Study First Received: | October 7, 2009 |
| Last Updated: | May 9, 2011 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Medicine and Dentistry New Jersey:
|
prostate cancer |
Additional relevant MeSH terms:
|
Prostatic Neoplasms Genital Neoplasms, Male Urogenital Neoplasms Neoplasms by Site |
Neoplasms Genital Diseases, Male Prostatic Diseases |
ClinicalTrials.gov processed this record on May 16, 2013